Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: The randomized, controlled EMPA-VISION trial

Hundertmark, M.; Adler, A.; Antoniades, C.; Coleman, R.; Griffin, J.L.; Holman, R.; Lamlum, H.; Lee, J.; Massey, D.; Miller, J.J.; Milton, J.; Monga, S.; Mózes, F.E.; Nazeer, A.; Raman, B.; Rider, O.; Rodgers, C.T.; Valkovič, Ladislav; Wicks, E.; Mahmod, M.; Neubauer, S.

doi:https://dx.doi.org/10.1161/CIRCULATIONAHA.122.062021

Number of the records: 1

Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: The randomized, controlled EMPA-VISION trial

Title	Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: The randomized, controlled EMPA-VISION trial. textový dokument (print)
Author	Hundertmark M.
Co-authors	Adler A.
	Antoniades C.
	Coleman R.
	Griffin J.L.
	Holman R.
	Lamlum H.
	Lee J.
	Massey D.
	Miller J.J.
	Milton J.
	Monga S.
	Mózes F.E.
	Nazeer A.
	Raman B.
	Rider O.
	Rodgers C.T.
	Valkovič Ladislav 1986 SAVMER - Ústav merania SAV ^SCOPUS ^RID ^ORCID
	Wicks E.
	Mahmod M.
	Neubauer S.

Source document	Circulation. Vol. 147, no. 22 (2023), p. 1654-1669
Language	eng - English
Country	US - United States of America
Document kind	rozpis článkov z periodík (rbx)
Citations	SU, S. - JI, X. - LI, T. - TENG, Y. - WANG, B.F. - HAN, X.W. - ZHAO, M.J. The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy. In FRONTIERS IN CARDIOVASCULAR MEDICINE. ISSN 2297-055X, DEC 6 2023, vol. 10. Dostupné na: https://doi.org/10.3389/fcvm.2023.1291450.
	RODRIGUES, E.A. - ROSA, C.M. - CAMPOS, D.H.S. - DAMATTO, F.C. - MURATA, G.M. - SOUZA, L.M. - PAGAN, L.U. - GATTO, M. - BROSLER, J.Y. - SOUZA, H.O.A. - MARTINS, M.M. - BASTOS, L.M. - TANNI, S.E. - OKOSHI, K. - OKOSHI, M.P. The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats. In DIABETOLOGY & METABOLIC SYNDROME. OCT 31 2023, vol. 15, no. 1. Dostupné na: https://doi.org/10.1186/s13098-023-01196-6.
	CARLUCCIO, E. - BIAGIOLI, P. - REBOLDI, G. - MENGONI, A. - LAUCIELLO, R. - ZUCHI, C. - D'ADDARIO, S. - BARDELLI, G. - AMBROSIO, G. Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies. In CARDIOVASCULAR DIABETOLOGY. SEP 2 2023, vol. 22, no. 1. Dostupné na: https://doi.org/10.1186/s12933-023-01970-w.
	GOLLEDGE, J. Can a genetic mutation associated with glycosuria teach us about the action of sodium-glucose cotransporter-2 inhibitors?. In CARDIOVASCULAR RESEARCH. ISSN 0008-6363, 2023 NOV 15 2023, vol. 119, no. 14, p. 2385-2386. Dostupné na: https://doi.org/10.1093/cvr/cvad142.
	GAO, S. - LIU, X.P. - LI, T.T. - CHEN, L. - FENG, Y.P. - WANG, Y.K. - YIN, Y.J. - LITTLE, P.J. - WU, X.Q. - XU, S.W. - JIANG, X.D. Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery. In ACTA PHARMACOLOGICA SINICA. ISSN 1671-4083, 2024 JAN 2024, vol. 45, no. 1, p. 23-35. Dostupné na: https://doi.org/10.1038/s41401-023-01152-0.
	LI, A.L. - LIAN, L. - CHEN, X.N. - CAI, W.H. - FAN, X.B. - FAN, Y.J. - LI, T.T. - XIE, Y.Y. - ZHANG, J.P. The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics. In FREE RADICAL BIOLOGY AND MEDICINE. ISSN 0891-5849, 2023 NOV 1 2023, vol. 208, p. 236-251. Dostupné na: https://doi.org/10.1016/j.freeradbiomed.2023.08.009.
	ABDULLAH, A. Targeting metabolism to treat heart failure. In CONDITIONING MEDICINE. ISSN 2577-3240, 2023, vol. 6, no. 2, p. 54-64. Dostupné na: http://www.conditionmed.org/Data/View/15028.
	TAN, W. - WANG, Y. - CHENG, S. - LIU, Z. - XIE, M. - SONG, L. - QIU, Q. - WANG, X. - LI, Z. - LIU, T. - GUO, F. - WANG, J. - ZHOU, X. AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis. In JOURNAL OF ADVANCED RESEARCH, 2024. ISSN 20901232. Dostupné na: https://doi.org/10.1016/j.jare.2024.02.015.
	TRIPOSKIADIS, F. - XANTHOPOULOS, A. - DRAKOS, S.G. - BOUDOULAS, K.D. - BRIASOULIS, A. - SKOULARIGIS, J. - TSIOUFIS, K. - BOUDOULAS, H. - STARLING, R.C. Back to the basics: The need for an etiological classification of chronic heart failure. In CURRENT PROBLEMS IN CARDIOLOGY, 2024, vol. 49, no. 4. ISSN 0146-2806. Dostupné na: https://doi.org/10.1016/j.cpcardiol.2024.102460.
	TSURUTA, H. - YAMAHARA, K. - YASUDA-YAMAHARA, M. – KUME, S. Emerging pathophysiological roles of ketone bodies. In PHYSIOLOGY, ISSN 1548-9213, 2024, dostupné na: https://doi.org/10.1152/physiol.00031.2023.
	WEI, J.F. - DUAN, X.F. - CHEN, J.Y. - ZHANG, D.W. - XU, J.D. - ZHUANG, J. - WANG, S. Metabolic adaptations in pressure overload hypertrophic heart. In HEART FAILURE REVIEWS. ISSN 1382-4147, JAN 2024, vol. 29, no. 1, p. 95-111. Dostupné na: https://doi.org/10.1007/s10741-023-10353-y.
Category	ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2023
Registered in	WOS
Registered in	SCOPUS
Registered in	CCC
DOI	10.1161/CIRCULATIONAHA.122.062021

article

	File name	Access	Size	Downloaded	Type	License
	Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin.pdf	available	1.3 MB	13	Publisher's version

Publication activities

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	A

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2023	2022	37.8	Q1	7.8	Q1

Number of the records: 1